enow.com Web Search

  1. Ad

    related to: dabigatran approved for stroke control and prevention devices for breathing

Search results

  1. Results from the WOW.Com Content Network
  2. Direct factor Xa inhibitors - Wikipedia

    en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

    [4] [5] [6] They are commonly prescribed to treat and prevent blood clots in veins, prevent stroke and embolism in people with non-valvular atrial fibrillation (AF) who have other risk factors, and prevent blood clots after routine knee and hip replacement surgery. [2] [3] [7]

  3. Discovery and development of direct thrombin inhibitors

    en.wikipedia.org/wiki/Discovery_and_development...

    Dabigatran etexilate was approved in Canada and Europe in 2008 for the prevention of VTE in patients undergoing hip- and knee surgery. In October 2010 the US FDA approved dabigatran etexilate for the prevention of stroke in patients with atrial fibrillation (AF).

  4. Dabigatran - Wikipedia

    en.wikipedia.org/wiki/Dabigatran

    Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. [ 6 ] [ 7 ] Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots. [ 6 ]

  5. Direct thrombin inhibitor - Wikipedia

    en.wikipedia.org/wiki/Direct_thrombin_inhibitor

    Dabigatran is an oral direct thrombin inhibitor. Dabigatran (Pradaxa) was found to be noninferior to Warfarin in prevention of ischemic stroke, as well as intracranial hemorrhage risk and overall mortality for non-valvular atrial fibrillation according to the RE-LY trial.

  6. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

  7. Ozempic Is Part of New Stroke Prevention Guidelines ... - AOL

    www.aol.com/ozempic-part-stroke-prevention...

    Control your cholesterol: High levels of LDL (“bad”) cholesterol can increase your risk of developing heart disease, which is a risk factor for stroke. The AHA suggests limiting sugary foods ...

  8. ELIQUIS® (apixaban) Approved In Japan For The Prevention Of ...

    www.aol.com/news/2012-12-26-eliquis-apixaban...

    This is the third approval for ELIQUIS for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, following approvals in the European Union and Canada.

  9. Intermittent positive pressure breathing - Wikipedia

    en.wikipedia.org/wiki/Intermittent_positive...

    Intermittent positive pressure breathing (IPPB) is a respiratory therapy treatment for people who are hypoventilating. While not a preferred method due to cost, [ 1 ] IPPB is used to expand the lungs, deliver aerosol medications, and in some circumstances ventilate the patient.

  1. Ad

    related to: dabigatran approved for stroke control and prevention devices for breathing
  1. Related searches dabigatran approved for stroke control and prevention devices for breathing

    dabigatran approved for strokepradaxa dabigatran
    dabigatran wikipediadabigatran etexilate